尿激酶静脉溶栓治疗急性心肌梗死的临床分析及护理干预  

Clinical analysis and nursing intervention of intravenous thrombolysis with urokinase in patients with acute myocardial infarction

作　　者：陈建妹 肖莉芳 

机构地区：[1]浙江省医疗健康集团杭州医院急诊科,浙江杭州310022 [2]浙江省医疗健康集团杭州医院ICU,浙江杭州310022

出　　处：《中国生化药物杂志》2017年第10期360-361,共2页Chinese Journal of Biochemical Pharmaceutics

摘　　要：目的分析尿激酶静脉溶栓治疗急性心肌梗死的临床分析及护理干预。方法选取本院2015年2月～2016年8月收治的40例急性心肌梗死患者为研究对象,随机分为对照组和试验组,每组患者各为20例。对照组患者进行常规治疗,静脉滴注硝酸甘油以及皮下注射低分子肝素,试验组在此基础上给予尿激酶静脉溶栓治疗。2组患者均进行合理的护理干预措施,提高护理质量。比较分析2组患者的临床治疗效果。结果试验组患者中,治疗有效例数为19例（95.0%）。对照组患者中,治疗有效例数为13例（65.0%）。可得,试验组患者的治疗有效率为高于对照组,差异具有统计学意义（P〈0.05）。对照组胸痛缓解时间为（15.32±7.21）h,试验组胸痛缓解时间为（2.72±0.67）h。试验组患者胸痛改善时间显著短于对照组,差异具有统计学意义（P〈0.05）。另外,试验组患者中发生并发症的概率为10.0%,显著低于对照组并发症发生率（40.0%）,差异具有统计学意义（P〈0.05）。结论尿激酶静脉溶栓治疗急性心肌梗死治疗效果较为理想,能够在很大程度上改善患者的临床症状,提高治疗有效率,治疗安全性较高。Objective To investigate and analyze the clinical analysis and nursing intervention of intravenous thrombolysis with urokinase in the treatment of acute myocardial infarction.Methods 40 patients with acute myocardial infarction treated in Hangzhou Hospital of Zhejiang Medical and Health Group from February 2015 to August 2016 were selected and randomly divided into the control group and the experimental group,with 20 patients in each group.The control group received routine treatment,intravenous drip of nitroglycerin and subcutaneous injection of low molecular weight heparin.On this basis,the experimental group was given urokinase intravenous thrombolysis treatment.Two groups of patients were given reasonable nursing intervention measures to improve the quality of care.The therapeutic effects of the experimental group and the control group were compared and analyzed.Results After the corresponding treatment,the effective number of patients in the experimental group was 19 cases（95.0%）.In the control group,the effective number of treatment was 13 cases（65.0%）.The effective rate of treatment in the experimental group was significantly higher than that in the control group,with statistical difference（P〈0.05）.The remission time of the chest pain in the control group was（15.32±7.21） h,and the remission time of the chest pain in the experimental group was（2.72±0.67） h.The improvement time of chest pain in the experimental group was significantly shorter than that in the control group,with statistical difference（P〈0.05）.In addition,the probability of complications in the experimental group was 10%,which was significantly lower than that in the control group（40.0%）,and there was a statistical difference（P〈0.05）.Conclusion Intravenous thrombolysis with urokinase in treatment of acute myocardial infarction treatment effect is ideal,can improve clinical symptoms in a large extent,improve the efficiency of treatment,the treatment of high safety,with the further promotion of the clinica

关 键 词：尿激酶 静脉溶栓治疗 心肌梗死 临床分析 护理干预 

分 类 号：R543.31[医药卫生—心血管疾病]